The advance opens up potential therapeutic uses for clearing unwanted proteins ...

Mixing an electrochemically active cathode material powder (left) with a new fluorine-free binder (middle) and a nontoxic ...

Estuary Biotherapeutics, which is developing gene therapies to treat kidney disease, has launched with $103 million in ...

Max M. Hansmann, an organic chemist at the Technical University of Dortmund who also works on carbon-atom transfer reactions, ...

A ruthenium-based reaction exploits the stronger carbon-deuterium bond to enrich one mirror-image form from a racemic mixture ...

HydRegen’s scientists are commercializing hydrogenase systems that work in conventional chemical reactors. Credit: HydRegen Enzymes are powerful tools for chemical synthesis, but their natural setting ...

In one of the largest tests to date, researchers find that satellites reliably spot the greenhouse gas across the board ...

Over $1 billion sat unused in US National Science Foundation (NSF) accounts as fiscal 2026 came to a close Oct. 1. A White ...

After successfully completing our previous strategic plan, we developed a new strategic plan in 2025. At its heart is our ...

In a recent related study, researchers in China also developed a heterogeneous hydroformylation catalyst based on rhodium. The group also uses nitrogen-containing molecules to enhance catalytic ...

Mary Jo Ondrechen, a distinguished professor of chemistry, says scientific fields are moving in an exciting direction ...

Biotechs in the US and Europe face challenges, but as a recent panel discussion made clear, the competition offers global ...